These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24988121)

  • 21. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial.
    Whyte J; Hart T; Vaccaro M; Grieb-Neff P; Risser A; Polansky M; Coslett HB
    Am J Phys Med Rehabil; 2004 Jun; 83(6):401-20. PubMed ID: 15166683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events in medication treatment-naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate.
    Wigal SB; Wong AA; Jun A; Stehli A; Steinberg-Epstein R; Lerner MA
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):149-56. PubMed ID: 22372513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study.
    Boellner SW; Stark JG; Krishnan S; Zhang Y
    Clin Ther; 2010 Feb; 32(2):252-64. PubMed ID: 20206783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of ADHD symptoms and global illness severity in adults treated with lisdexamfetamine dimesylate.
    Weisler RH; Babcock T; Adeyi B; Brams M
    Postgrad Med; 2014 Sep; 126(5):31-41. PubMed ID: 25295648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study.
    Biederman J; Boellner SW; Childress A; Lopez FA; Krishnan S; Zhang Y
    Biol Psychiatry; 2007 Nov; 62(9):970-6. PubMed ID: 17631866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate?
    Wigal SB; Jun A; Wong AA; Stehli A; Steinberg-Epstein R; Lerner MA
    Postgrad Med; 2010 Sep; 122(5):27-34. PubMed ID: 20861585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder.
    McGough JJ; Greenbaum M; Adeyi B; Babcock T; Scheckner B; Dirks B; Findling RL
    J Clin Psychopharmacol; 2012 Feb; 32(1):138-40. PubMed ID: 22217951
    [No Abstract]   [Full Text] [Related]  

  • 29. Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.
    Coghill DR; Banaschewski T; Bliss C; Robertson B; Zuddas A
    CNS Drugs; 2018 Jan; 32(1):85-95. PubMed ID: 29383572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
    Brown TE; Brams M; Gasior M; Adeyi B; Babcock T; Dirks B; Scheckner B; Wigal T
    Curr Med Res Opin; 2011; 27 Suppl 2():23-33. PubMed ID: 21973229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A series of n-of-1 trials of stimulants in brain injured children.
    Nikles J; Mitchell G; McKinlay L; Waugh MC; Epps A; Carmont SA; Schluter PJ; Lloyd O; Senior H
    NeuroRehabilitation; 2017; 40(1):11-21. PubMed ID: 27814302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.
    Brams M; Moon E; Pucci M; López FA
    Curr Med Res Opin; 2010 Aug; 26(8):1809-25. PubMed ID: 20491612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study.
    Young JL
    Psychiatry Res; 2013 May; 207(1-2):127-33. PubMed ID: 23062791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
    Coghill DR; Rhodes SM; Matthews K
    Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire.
    Biederman J; Fried R; Hammerness P; Surman C; Mehler B; Petty CR; Faraone SV; Miller C; Bourgeois M; Meller B; Godfrey KM; Baer L; Reimer B
    J Adolesc Health; 2012 Dec; 51(6):601-7. PubMed ID: 23174471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lisdexamfetamine dimesylate.
    Elia J; Easley C; Kirkpatrick P
    Nat Rev Drug Discov; 2007 May; 6(5):343-4. PubMed ID: 17539056
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.
    McDonald BC; Flashman LA; Arciniegas DB; Ferguson RJ; Xing L; Harezlak J; Sprehn GC; Hammond FM; Maerlender AC; Kruck CL; Gillock KL; Frey K; Wall RN; Saykin AJ; McAllister TW
    Neuropsychopharmacology; 2017 Aug; 42(9):1766-1775. PubMed ID: 27874023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychopharmacologic treatment of acquired attention disorders in children with brain injury.
    Mahalick DM; Carmel PW; Greenberg JP; Molofsky W; Brown JA; Heary RF; Marks D; Zampella E; Hodosh R; von der Schmidt E
    Pediatr Neurosurg; 1998 Sep; 29(3):121-6. PubMed ID: 9838263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.